Congenital stationary night blindness (CSNB) is caused by mutations in a specific calcium channel. A comprehensive proteomic study by researchers at the University of Innsbruck now reveals how these mutations trigger complex, mutation-specific molecular changes. For the first time, this work provides a solid foundation for the development of personalized therapeutic approaches.
This article was originally published on MedicalXpress.com

